A top executive offloaded 52,900 shares, reducing his direct stake by 54% amid a net income loss of $171.0 million.
Bausch + Lomb Corporation’s SVP, Controller, and CAO Frederick Munsch sold 52,900 shares on Aug. 10, 2026, at a weighted average price of $16.78. The transaction totaled nearly $900,000, based on SEC filings.
The sale reduced Munsch’s direct common stock position by 54%, leaving him with 45,831 shares. The stock closed at $16.87 on Aug. 11, slightly above the sale price. The company, with a $6.0 billion market cap, reported trailing twelve-month revenue of $5.3 billion and a net loss of $171.0 million.
Bausch + Lomb operates in vision care, ophthalmic pharmaceuticals, and surgical segments, serving global eye health markets.